WC
Whitefort Capital Management, LP disclosed a 8% stake in ABUS
Whitefort Capital Management, LP reported owning 8% of Arbutus Biopharma Corp (ABUS) (15,794,261 shares) in a Schedule 13G filed Sep 4, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.